Mimedx (MDXG) Capital Expenditures Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 143.40% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 51.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.19% |
| Dec 31, 2025 | 8.37% |
| Sep 30, 2025 | 12.28% |
| Jun 30, 2025 | 70.48% |
| Mar 31, 2025 | -67.05% |
| Dec 31, 2024 | -86.76% |
| Sep 30, 2024 | 118.35% |
| Jun 30, 2024 | -64.88% |
| Mar 31, 2024 | 80.73% |
| Dec 31, 2023 | 197.90% |
| Sep 30, 2023 | -367.05% |
| Jun 30, 2023 | -21.32% |
| Mar 31, 2023 | 436.44% |
| Dec 31, 2022 | 105.23% |
| Sep 30, 2022 | -36.20% |
| Jun 30, 2022 | -6.17% |
| Mar 31, 2022 | -93.92% |
| Dec 31, 2021 | -84.92% |
| Sep 30, 2021 | -16.10% |
| Jun 30, 2021 | -1.22% |
| Mar 31, 2021 | 91.99% |
| Dec 31, 2020 | 209.18% |
| Sep 30, 2020 | 317.95% |
| Jun 30, 2020 | 63.35% |
| Mar 31, 2020 | 56.02% |
| Dec 31, 2019 | -61.89% |
| Sep 30, 2019 | -92.39% |
| Jun 30, 2019 | -89.85% |
| Mar 31, 2019 | -78.89% |
| Dec 31, 2018 | 62.15% |
| Sep 30, 2018 | -48.56% |
| Jun 30, 2018 | 49,340.00% |
| Mar 31, 2018 | 30,590.00% |
| Dec 31, 2017 | 121.70% |
| Sep 30, 2017 | 157.63% |
| Jun 30, 2017 | -99.71% |
| Mar 31, 2017 | -99.50% |
| Dec 31, 2016 | -414.90% |
| Sep 30, 2016 | -7.04% |
| Jun 30, 2016 | 49.83% |
| Mar 31, 2016 | 49.07% |
| Dec 31, 2015 | -33.13% |
| Sep 30, 2015 | 6,059.26% |
| Jun 30, 2015 | 3,920.69% |
| Mar 31, 2015 | 3,981.82% |
| Dec 31, 2014 | 226.52% |
| Sep 30, 2014 | -97.17% |
| Jun 30, 2014 | -97.04% |
| Mar 31, 2014 | -55.12% |
| Dec 31, 2013 | -929.91% |
| Sep 30, 2013 | 484.87% |
| Jun 30, 2013 | 310.65% |
| Dec 31, 2012 | -51.63% |
| Sep 30, 2012 | 213.90% |
| Jun 30, 2012 | 657.14% |